CPC C07K 16/24 (2013.01) [A61K 38/1709 (2013.01); A61K 48/00 (2013.01); C07K 14/4701 (2013.01); C07K 14/4702 (2013.01); C07K 16/18 (2013.01); C12N 15/113 (2013.01); C12Q 1/6886 (2013.01); G01N 33/577 (2013.01); G01N 33/6896 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/76 (2013.01); C12N 2310/11 (2013.01); C12N 2310/141 (2013.01); C12Q 2600/156 (2013.01); G01N 2333/47 (2013.01)] | 16 Claims |
1. A method of treating a glioblastoma in a subject in need thereof, comprising administering to the subject an effective amount of an antibody or a fragment thereof that specifically binds to a family with sequence similarity 19 (FAM19A5) protein (anti-FAM19A5 antibody).
|